Form 8-K - Current report:
SEC Accession No. 0001731122-20-001339
Filing Date
2020-12-28
Accepted
2020-12-28 17:28:32
Documents
2
Period of Report
2020-12-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e2308_8-k.htm 8-K 16835
2 EXHIBIT 99.1 e2308_ex99-1.htm EX-99.1 57432
  Complete submission text file 0001731122-20-001339.txt   75532
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 201419267
SIC: 8731 Services-Commercial Physical & Biological Research